- Capital Cube•2 months ago
Click here to see latest analysisOhr Pharmaceutical, Inc. reports financial results for the quarter ended March 31, 2016.AnalysisSummary numbers: Revenues of USD 0 million, Net Earnings of USD -5.28 million.The company did not record any revenues for the last twelve months making the comparison of net margin versus asset turnover meaningless.OHRP-US‘s earnings and EBITDA are […] (Read more...) The post Ohr Pharmaceutical, Inc. :OHRP-US: Earnings Analysis: Q2, 2016 By the Numbers : June 8, 2016 appeared first on CapitalCube.
This will warm your heart.
- Associated Press•2 months ago
The New York-based company said it had a loss of 17 cents per share. In the final minutes of trading on Tuesday, the company's shares hit $3.16. A year ago, they were trading at $2.74. _____ This story ...
|Bid||2.48 x 300|
|Ask||3.40 x 1800|
|52wk Range||2.20 - 6.56|
|Day's Range||2.55 - 2.63|
|Avg Vol (3m)||117,895|
As of 4:00 PM EDT. Market closed.